Global Humira Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Humira market size is predicted to grow from US$ 14060 million in 2025 to US$ 8192 million in 2031; it is expected to grow at a CAGR of -8.6% from 2025 to 2031.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
LP Information, Inc. (LPI) ' newest research report, the “Humira Industry Forecast” looks at past sales and reviews total world Humira sales in 2024, providing a comprehensive analysis by region and market sector of projected Humira sales for 2025 through 2031. With Humira sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Humira industry.
This Insight Report provides a comprehensive analysis of the global Humira landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Humira portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Humira market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Humira and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Humira.
This report presents a comprehensive overview, market shares, and growth opportunities of Humira market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Humira market?
What factors are driving Humira market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Humira market opportunities vary by end market size?
How does Humira break out by Type, by Application?
The global Humira market size is predicted to grow from US$ 14060 million in 2025 to US$ 8192 million in 2031; it is expected to grow at a CAGR of -8.6% from 2025 to 2031.
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation.
Humira is used to treat many inflammatory conditions in adults, such as ulcerative colitis, Rheumatoid Arthritis, psoriatic arthritis, Ankylosing Spondylitis, plaque psoriasis, and a skin condition called hidradenitis suppurativa.
Humira is also used in adults and children to treat Crohn's disease or juvenile idiopathic arthritis.
In 2014, in India, the first adalimumab biosimilar came to market at a price of $200. Two years later, another Indian drugmaker, Torrent Pharmaceuticals, launched a second biosimilar. Humira's U.S. patent expired in 2016.
The classification of Humira includes Humira Syringe and Humira Pen. The proportion of Humira Syringe is about 78%.
Humira is widely used for Ankylosing Spondylitis, Rheumatoid Arthritis, Crohn’s disease and other disease. The most proportion of Humira is for Ankylosing Spondylitis, and the proportion is about 43%.
USA is the largest market, with a sales market share nearly 65%. Following USA, Europe is the second largest market with the sales market share of 30%.
Market competition will intense. AbbVie, Eisai, Cadila Healthcare, Torrent Pharmaceuticals, Amgen and Boehringer Ingelheim are the key manufacturters of Humira. AbbVie is the leader of this industry by 97% market shares.
LP Information, Inc. (LPI) ' newest research report, the “Humira Industry Forecast” looks at past sales and reviews total world Humira sales in 2024, providing a comprehensive analysis by region and market sector of projected Humira sales for 2025 through 2031. With Humira sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Humira industry.
This Insight Report provides a comprehensive analysis of the global Humira landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Humira portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Humira market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Humira and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Humira.
This report presents a comprehensive overview, market shares, and growth opportunities of Humira market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Humira Syringe
- Humira Pen
- Ankylosing Spondylitis
- Rheumatoid Arthritis
- Crohn’s Disease
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Eisai
- Cadila Healthcare
- Torrent Pharmaceuticals
- Amgen
- Boehringer Ingelheim
What is the 10-year outlook for the global Humira market?
What factors are driving Humira market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Humira market opportunities vary by end market size?
How does Humira break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Humira Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Humira by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Humira by Country/Region, 2020, 2024 & 2031
2.2 Humira Segment by Type
2.2.1 Humira Syringe
2.2.2 Humira Pen
2.3 Humira Sales by Type
2.3.1 Global Humira Sales Market Share by Type (2020-2025)
2.3.2 Global Humira Revenue and Market Share by Type (2020-2025)
2.3.3 Global Humira Sale Price by Type (2020-2025)
2.4 Humira Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Rheumatoid Arthritis
2.4.3 Crohn’s Disease
2.4.4 Others
2.5 Humira Sales by Application
2.5.1 Global Humira Sale Market Share by Application (2020-2025)
2.5.2 Global Humira Revenue and Market Share by Application (2020-2025)
2.5.3 Global Humira Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Humira Breakdown Data by Company
3.1.1 Global Humira Annual Sales by Company (2020-2025)
3.1.2 Global Humira Sales Market Share by Company (2020-2025)
3.2 Global Humira Annual Revenue by Company (2020-2025)
3.2.1 Global Humira Revenue by Company (2020-2025)
3.2.2 Global Humira Revenue Market Share by Company (2020-2025)
3.3 Global Humira Sale Price by Company
3.4 Key Manufacturers Humira Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Humira Product Location Distribution
3.4.2 Players Humira Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
4.1 World Historic Humira Market Size by Geographic Region (2020-2025)
4.1.1 Global Humira Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Humira Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Humira Market Size by Country/Region (2020-2025)
4.2.1 Global Humira Annual Sales by Country/Region (2020-2025)
4.2.2 Global Humira Annual Revenue by Country/Region (2020-2025)
4.3 Americas Humira Sales Growth
4.4 APAC Humira Sales Growth
4.5 Europe Humira Sales Growth
4.6 Middle East & Africa Humira Sales Growth
5 AMERICAS
5.1 Americas Humira Sales by Country
5.1.1 Americas Humira Sales by Country (2020-2025)
5.1.2 Americas Humira Revenue by Country (2020-2025)
5.2 Americas Humira Sales by Type (2020-2025)
5.3 Americas Humira Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Humira Sales by Region
6.1.1 APAC Humira Sales by Region (2020-2025)
6.1.2 APAC Humira Revenue by Region (2020-2025)
6.2 APAC Humira Sales by Type (2020-2025)
6.3 APAC Humira Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Humira by Country
7.1.1 Europe Humira Sales by Country (2020-2025)
7.1.2 Europe Humira Revenue by Country (2020-2025)
7.2 Europe Humira Sales by Type (2020-2025)
7.3 Europe Humira Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Humira by Country
8.1.1 Middle East & Africa Humira Sales by Country (2020-2025)
8.1.2 Middle East & Africa Humira Revenue by Country (2020-2025)
8.2 Middle East & Africa Humira Sales by Type (2020-2025)
8.3 Middle East & Africa Humira Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Humira
10.3 Manufacturing Process Analysis of Humira
10.4 Industry Chain Structure of Humira
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Humira Distributors
11.3 Humira Customer
12 WORLD FORECAST REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
12.1 Global Humira Market Size Forecast by Region
12.1.1 Global Humira Forecast by Region (2026-2031)
12.1.2 Global Humira Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Humira Forecast by Type (2026-2031)
12.7 Global Humira Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Humira Product Portfolios and Specifications
13.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Humira Product Portfolios and Specifications
13.2.3 Eisai Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Cadila Healthcare
13.3.1 Cadila Healthcare Company Information
13.3.2 Cadila Healthcare Humira Product Portfolios and Specifications
13.3.3 Cadila Healthcare Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cadila Healthcare Main Business Overview
13.3.5 Cadila Healthcare Latest Developments
13.4 Torrent Pharmaceuticals
13.4.1 Torrent Pharmaceuticals Company Information
13.4.2 Torrent Pharmaceuticals Humira Product Portfolios and Specifications
13.4.3 Torrent Pharmaceuticals Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Torrent Pharmaceuticals Main Business Overview
13.4.5 Torrent Pharmaceuticals Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Humira Product Portfolios and Specifications
13.5.3 Amgen Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Humira Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Humira Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Humira Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Humira Syringe
Table 4. Major Players of Humira Pen
Table 5. Global Humira Sales byType (2020-2025) & (K Units)
Table 6. Global Humira Sales Market Share byType (2020-2025)
Table 7. Global Humira Revenue byType (2020-2025) & ($ million)
Table 8. Global Humira Revenue Market Share byType (2020-2025)
Table 9. Global Humira Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Humira Sale by Application (2020-2025) & (K Units)
Table 11. Global Humira Sale Market Share by Application (2020-2025)
Table 12. Global Humira Revenue by Application (2020-2025) & ($ million)
Table 13. Global Humira Revenue Market Share by Application (2020-2025)
Table 14. Global Humira Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Humira Sales by Company (2020-2025) & (K Units)
Table 16. Global Humira Sales Market Share by Company (2020-2025)
Table 17. Global Humira Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Humira Revenue Market Share by Company (2020-2025)
Table 19. Global Humira Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Humira Producing Area Distribution and Sales Area
Table 21. Players Humira Products Offered
Table 22. Humira Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Humira Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Humira Sales Market Share Geographic Region (2020-2025)
Table 27. Global Humira Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Humira Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Humira Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Humira Sales Market Share by Country/Region (2020-2025)
Table 31. Global Humira Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Humira Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Humira Sales by Country (2020-2025) & (K Units)
Table 34. Americas Humira Sales Market Share by Country (2020-2025)
Table 35. Americas Humira Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Humira Sales byType (2020-2025) & (K Units)
Table 37. Americas Humira Sales by Application (2020-2025) & (K Units)
Table 38. APAC Humira Sales by Region (2020-2025) & (K Units)
Table 39. APAC Humira Sales Market Share by Region (2020-2025)
Table 40. APAC Humira Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Humira Sales byType (2020-2025) & (K Units)
Table 42. APAC Humira Sales by Application (2020-2025) & (K Units)
Table 43. Europe Humira Sales by Country (2020-2025) & (K Units)
Table 44. Europe Humira Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Humira Sales byType (2020-2025) & (K Units)
Table 46. Europe Humira Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Humira Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Humira Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Humira Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Humira Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Humira
Table 52. Key Market Challenges & Risks of Humira
Table 53. Key IndustryTrends of Humira
Table 54. Humira Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Humira Distributors List
Table 57. Humira Customer List
Table 58. Global Humira SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Humira RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Humira SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Humira Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Humira SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Humira Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Humira SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Humira RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Humira SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Humira RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Humira SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Humira RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Humira SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Humira RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. AbbVie Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 73. AbbVie Humira Product Portfolios and Specifications
Table 74. AbbVie Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. AbbVie Main Business
Table 76. AbbVie Latest Developments
Table 77. Eisai Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 78. Eisai Humira Product Portfolios and Specifications
Table 79. Eisai Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Eisai Main Business
Table 81. Eisai Latest Developments
Table 82. Cadila Healthcare Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 83. Cadila Healthcare Humira Product Portfolios and Specifications
Table 84. Cadila Healthcare Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Cadila Healthcare Main Business
Table 86. Cadila Healthcare Latest Developments
Table 87.Torrent Pharmaceuticals Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 88.Torrent Pharmaceuticals Humira Product Portfolios and Specifications
Table 89.Torrent Pharmaceuticals Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90.Torrent Pharmaceuticals Main Business
Table 91.Torrent Pharmaceuticals Latest Developments
Table 92. Amgen Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 93. Amgen Humira Product Portfolios and Specifications
Table 94. Amgen Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Amgen Main Business
Table 96. Amgen Latest Developments
Table 97. Boehringer Ingelheim Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Humira Product Portfolios and Specifications
Table 99. Boehringer Ingelheim Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
LIST OFFIGURES
Figure 1. Picture of Humira
Figure 2. Humira Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Humira Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Humira Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Humira Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Humira Sales Market Share by Country/Region (2024)
Figure 10. Humira Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Humira Syringe
Figure 12. Product Picture of Humira Pen
Figure 13. Global Humira Sales Market Share byType in 2025
Figure 14. Global Humira Revenue Market Share byType (2020-2025)
Figure 15. Humira Consumed in Ankylosing Spondylitis
Figure 16. Global Humira Market: Ankylosing Spondylitis (2020-2025) & (K Units)
Figure 17. Humira Consumed in Rheumatoid Arthritis
Figure 18. Global Humira Market: Rheumatoid Arthritis (2020-2025) & (K Units)
Figure 19. Humira Consumed in Crohn’s Disease
Figure 20. Global Humira Market: Crohn’s Disease (2020-2025) & (K Units)
Figure 21. Humira Consumed in Others
Figure 22. Global Humira Market: Others (2020-2025) & (K Units)
Figure 23. Global Humira Sale Market Share by Application (2024)
Figure 24. Global Humira Revenue Market Share by Application in 2025
Figure 25. Humira Sales by Company in 2025 (K Units)
Figure 26. Global Humira Sales Market Share by Company in 2025
Figure 27. Humira Revenue by Company in 2025 ($ millions)
Figure 28. Global Humira Revenue Market Share by Company in 2025
Figure 29. Global Humira Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Humira Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Humira Sales 2020-2025 (K Units)
Figure 32. Americas Humira Revenue 2020-2025 ($ millions)
Figure 33. APAC Humira Sales 2020-2025 (K Units)
Figure 34. APAC Humira Revenue 2020-2025 ($ millions)
Figure 35. Europe Humira Sales 2020-2025 (K Units)
Figure 36. Europe Humira Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Humira Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Humira Revenue 2020-2025 ($ millions)
Figure 39. Americas Humira Sales Market Share by Country in 2025
Figure 40. Americas Humira Revenue Market Share by Country (2020-2025)
Figure 41. Americas Humira Sales Market Share byType (2020-2025)
Figure 42. Americas Humira Sales Market Share by Application (2020-2025)
Figure 43. United States Humira Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Humira Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Humira Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Humira Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Humira Sales Market Share by Region in 2025
Figure 48. APAC Humira Revenue Market Share by Region (2020-2025)
Figure 49. APAC Humira Sales Market Share byType (2020-2025)
Figure 50. APAC Humira Sales Market Share by Application (2020-2025)
Figure 51. China Humira Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Humira Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Humira Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Humira Revenue Growth 2020-2025 ($ millions)
Figure 55. India Humira Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Humira Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Humira Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Humira Sales Market Share by Country in 2025
Figure 59. Europe Humira Revenue Market Share by Country (2020-2025)
Figure 60. Europe Humira Sales Market Share byType (2020-2025)
Figure 61. Europe Humira Sales Market Share by Application (2020-2025)
Figure 62. Germany Humira Revenue Growth 2020-2025 ($ millions)
Figure 63.France Humira Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Humira Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Humira Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Humira Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Humira Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Humira Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Humira Sales Market Share by Application (2020-2025)
Figure 70. Egypt Humira Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Humira Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Humira Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Humira Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Humira Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Humira in 2025
Figure 76. Manufacturing Process Analysis of Humira
Figure 77. Industry Chain Structure of Humira
Figure 78. Channels of Distribution
Figure 79. Global Humira Sales MarketForecast by Region (2026-2031)
Figure 80. Global Humira Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Humira Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Humira Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Humira Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Humira Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Humira Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Humira by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Humira by Country/Region, 2020, 2024 & 2031
2.2 Humira Segment by Type
2.2.1 Humira Syringe
2.2.2 Humira Pen
2.3 Humira Sales by Type
2.3.1 Global Humira Sales Market Share by Type (2020-2025)
2.3.2 Global Humira Revenue and Market Share by Type (2020-2025)
2.3.3 Global Humira Sale Price by Type (2020-2025)
2.4 Humira Segment by Application
2.4.1 Ankylosing Spondylitis
2.4.2 Rheumatoid Arthritis
2.4.3 Crohn’s Disease
2.4.4 Others
2.5 Humira Sales by Application
2.5.1 Global Humira Sale Market Share by Application (2020-2025)
2.5.2 Global Humira Revenue and Market Share by Application (2020-2025)
2.5.3 Global Humira Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Humira Breakdown Data by Company
3.1.1 Global Humira Annual Sales by Company (2020-2025)
3.1.2 Global Humira Sales Market Share by Company (2020-2025)
3.2 Global Humira Annual Revenue by Company (2020-2025)
3.2.1 Global Humira Revenue by Company (2020-2025)
3.2.2 Global Humira Revenue Market Share by Company (2020-2025)
3.3 Global Humira Sale Price by Company
3.4 Key Manufacturers Humira Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Humira Product Location Distribution
3.4.2 Players Humira Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
4.1 World Historic Humira Market Size by Geographic Region (2020-2025)
4.1.1 Global Humira Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Humira Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Humira Market Size by Country/Region (2020-2025)
4.2.1 Global Humira Annual Sales by Country/Region (2020-2025)
4.2.2 Global Humira Annual Revenue by Country/Region (2020-2025)
4.3 Americas Humira Sales Growth
4.4 APAC Humira Sales Growth
4.5 Europe Humira Sales Growth
4.6 Middle East & Africa Humira Sales Growth
5 AMERICAS
5.1 Americas Humira Sales by Country
5.1.1 Americas Humira Sales by Country (2020-2025)
5.1.2 Americas Humira Revenue by Country (2020-2025)
5.2 Americas Humira Sales by Type (2020-2025)
5.3 Americas Humira Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Humira Sales by Region
6.1.1 APAC Humira Sales by Region (2020-2025)
6.1.2 APAC Humira Revenue by Region (2020-2025)
6.2 APAC Humira Sales by Type (2020-2025)
6.3 APAC Humira Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Humira by Country
7.1.1 Europe Humira Sales by Country (2020-2025)
7.1.2 Europe Humira Revenue by Country (2020-2025)
7.2 Europe Humira Sales by Type (2020-2025)
7.3 Europe Humira Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Humira by Country
8.1.1 Middle East & Africa Humira Sales by Country (2020-2025)
8.1.2 Middle East & Africa Humira Revenue by Country (2020-2025)
8.2 Middle East & Africa Humira Sales by Type (2020-2025)
8.3 Middle East & Africa Humira Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Humira
10.3 Manufacturing Process Analysis of Humira
10.4 Industry Chain Structure of Humira
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Humira Distributors
11.3 Humira Customer
12 WORLD FORECAST REVIEW FOR HUMIRA BY GEOGRAPHIC REGION
12.1 Global Humira Market Size Forecast by Region
12.1.1 Global Humira Forecast by Region (2026-2031)
12.1.2 Global Humira Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Humira Forecast by Type (2026-2031)
12.7 Global Humira Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 AbbVie
13.1.1 AbbVie Company Information
13.1.2 AbbVie Humira Product Portfolios and Specifications
13.1.3 AbbVie Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 AbbVie Main Business Overview
13.1.5 AbbVie Latest Developments
13.2 Eisai
13.2.1 Eisai Company Information
13.2.2 Eisai Humira Product Portfolios and Specifications
13.2.3 Eisai Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Eisai Main Business Overview
13.2.5 Eisai Latest Developments
13.3 Cadila Healthcare
13.3.1 Cadila Healthcare Company Information
13.3.2 Cadila Healthcare Humira Product Portfolios and Specifications
13.3.3 Cadila Healthcare Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Cadila Healthcare Main Business Overview
13.3.5 Cadila Healthcare Latest Developments
13.4 Torrent Pharmaceuticals
13.4.1 Torrent Pharmaceuticals Company Information
13.4.2 Torrent Pharmaceuticals Humira Product Portfolios and Specifications
13.4.3 Torrent Pharmaceuticals Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Torrent Pharmaceuticals Main Business Overview
13.4.5 Torrent Pharmaceuticals Latest Developments
13.5 Amgen
13.5.1 Amgen Company Information
13.5.2 Amgen Humira Product Portfolios and Specifications
13.5.3 Amgen Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Amgen Main Business Overview
13.5.5 Amgen Latest Developments
13.6 Boehringer Ingelheim
13.6.1 Boehringer Ingelheim Company Information
13.6.2 Boehringer Ingelheim Humira Product Portfolios and Specifications
13.6.3 Boehringer Ingelheim Humira Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Boehringer Ingelheim Main Business Overview
13.6.5 Boehringer Ingelheim Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Humira Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Humira Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Humira Syringe
Table 4. Major Players of Humira Pen
Table 5. Global Humira Sales byType (2020-2025) & (K Units)
Table 6. Global Humira Sales Market Share byType (2020-2025)
Table 7. Global Humira Revenue byType (2020-2025) & ($ million)
Table 8. Global Humira Revenue Market Share byType (2020-2025)
Table 9. Global Humira Sale Price byType (2020-2025) & (USD/Unit)
Table 10. Global Humira Sale by Application (2020-2025) & (K Units)
Table 11. Global Humira Sale Market Share by Application (2020-2025)
Table 12. Global Humira Revenue by Application (2020-2025) & ($ million)
Table 13. Global Humira Revenue Market Share by Application (2020-2025)
Table 14. Global Humira Sale Price by Application (2020-2025) & (USD/Unit)
Table 15. Global Humira Sales by Company (2020-2025) & (K Units)
Table 16. Global Humira Sales Market Share by Company (2020-2025)
Table 17. Global Humira Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Humira Revenue Market Share by Company (2020-2025)
Table 19. Global Humira Sale Price by Company (2020-2025) & (USD/Unit)
Table 20. Key Manufacturers Humira Producing Area Distribution and Sales Area
Table 21. Players Humira Products Offered
Table 22. Humira Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Humira Sales by Geographic Region (2020-2025) & (K Units)
Table 26. Global Humira Sales Market Share Geographic Region (2020-2025)
Table 27. Global Humira Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Humira Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Humira Sales by Country/Region (2020-2025) & (K Units)
Table 30. Global Humira Sales Market Share by Country/Region (2020-2025)
Table 31. Global Humira Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Humira Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Humira Sales by Country (2020-2025) & (K Units)
Table 34. Americas Humira Sales Market Share by Country (2020-2025)
Table 35. Americas Humira Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Humira Sales byType (2020-2025) & (K Units)
Table 37. Americas Humira Sales by Application (2020-2025) & (K Units)
Table 38. APAC Humira Sales by Region (2020-2025) & (K Units)
Table 39. APAC Humira Sales Market Share by Region (2020-2025)
Table 40. APAC Humira Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Humira Sales byType (2020-2025) & (K Units)
Table 42. APAC Humira Sales by Application (2020-2025) & (K Units)
Table 43. Europe Humira Sales by Country (2020-2025) & (K Units)
Table 44. Europe Humira Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Humira Sales byType (2020-2025) & (K Units)
Table 46. Europe Humira Sales by Application (2020-2025) & (K Units)
Table 47. Middle East & Africa Humira Sales by Country (2020-2025) & (K Units)
Table 48. Middle East & Africa Humira Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Humira Sales byType (2020-2025) & (K Units)
Table 50. Middle East & Africa Humira Sales by Application (2020-2025) & (K Units)
Table 51. Key Market Drivers & Growth Opportunities of Humira
Table 52. Key Market Challenges & Risks of Humira
Table 53. Key IndustryTrends of Humira
Table 54. Humira Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Humira Distributors List
Table 57. Humira Customer List
Table 58. Global Humira SalesForecast by Region (2026-2031) & (K Units)
Table 59. Global Humira RevenueForecast by Region (2026-2031) & ($ millions)
Table 60. Americas Humira SalesForecast by Country (2026-2031) & (K Units)
Table 61. Americas Humira Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 62. APAC Humira SalesForecast by Region (2026-2031) & (K Units)
Table 63. APAC Humira Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 64. Europe Humira SalesForecast by Country (2026-2031) & (K Units)
Table 65. Europe Humira RevenueForecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Humira SalesForecast by Country (2026-2031) & (K Units)
Table 67. Middle East & Africa Humira RevenueForecast by Country (2026-2031) & ($ millions)
Table 68. Global Humira SalesForecast byType (2026-2031) & (K Units)
Table 69. Global Humira RevenueForecast byType (2026-2031) & ($ millions)
Table 70. Global Humira SalesForecast by Application (2026-2031) & (K Units)
Table 71. Global Humira RevenueForecast by Application (2026-2031) & ($ millions)
Table 72. AbbVie Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 73. AbbVie Humira Product Portfolios and Specifications
Table 74. AbbVie Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. AbbVie Main Business
Table 76. AbbVie Latest Developments
Table 77. Eisai Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 78. Eisai Humira Product Portfolios and Specifications
Table 79. Eisai Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 80. Eisai Main Business
Table 81. Eisai Latest Developments
Table 82. Cadila Healthcare Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 83. Cadila Healthcare Humira Product Portfolios and Specifications
Table 84. Cadila Healthcare Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 85. Cadila Healthcare Main Business
Table 86. Cadila Healthcare Latest Developments
Table 87.Torrent Pharmaceuticals Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 88.Torrent Pharmaceuticals Humira Product Portfolios and Specifications
Table 89.Torrent Pharmaceuticals Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 90.Torrent Pharmaceuticals Main Business
Table 91.Torrent Pharmaceuticals Latest Developments
Table 92. Amgen Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 93. Amgen Humira Product Portfolios and Specifications
Table 94. Amgen Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 95. Amgen Main Business
Table 96. Amgen Latest Developments
Table 97. Boehringer Ingelheim Basic Information, Humira Manufacturing Base, Sales Area and Its Competitors
Table 98. Boehringer Ingelheim Humira Product Portfolios and Specifications
Table 99. Boehringer Ingelheim Humira Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 100. Boehringer Ingelheim Main Business
Table 101. Boehringer Ingelheim Latest Developments
LIST OFFIGURES
Figure 1. Picture of Humira
Figure 2. Humira Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Humira Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Humira Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Humira Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Humira Sales Market Share by Country/Region (2024)
Figure 10. Humira Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Humira Syringe
Figure 12. Product Picture of Humira Pen
Figure 13. Global Humira Sales Market Share byType in 2025
Figure 14. Global Humira Revenue Market Share byType (2020-2025)
Figure 15. Humira Consumed in Ankylosing Spondylitis
Figure 16. Global Humira Market: Ankylosing Spondylitis (2020-2025) & (K Units)
Figure 17. Humira Consumed in Rheumatoid Arthritis
Figure 18. Global Humira Market: Rheumatoid Arthritis (2020-2025) & (K Units)
Figure 19. Humira Consumed in Crohn’s Disease
Figure 20. Global Humira Market: Crohn’s Disease (2020-2025) & (K Units)
Figure 21. Humira Consumed in Others
Figure 22. Global Humira Market: Others (2020-2025) & (K Units)
Figure 23. Global Humira Sale Market Share by Application (2024)
Figure 24. Global Humira Revenue Market Share by Application in 2025
Figure 25. Humira Sales by Company in 2025 (K Units)
Figure 26. Global Humira Sales Market Share by Company in 2025
Figure 27. Humira Revenue by Company in 2025 ($ millions)
Figure 28. Global Humira Revenue Market Share by Company in 2025
Figure 29. Global Humira Sales Market Share by Geographic Region (2020-2025)
Figure 30. Global Humira Revenue Market Share by Geographic Region in 2025
Figure 31. Americas Humira Sales 2020-2025 (K Units)
Figure 32. Americas Humira Revenue 2020-2025 ($ millions)
Figure 33. APAC Humira Sales 2020-2025 (K Units)
Figure 34. APAC Humira Revenue 2020-2025 ($ millions)
Figure 35. Europe Humira Sales 2020-2025 (K Units)
Figure 36. Europe Humira Revenue 2020-2025 ($ millions)
Figure 37. Middle East & Africa Humira Sales 2020-2025 (K Units)
Figure 38. Middle East & Africa Humira Revenue 2020-2025 ($ millions)
Figure 39. Americas Humira Sales Market Share by Country in 2025
Figure 40. Americas Humira Revenue Market Share by Country (2020-2025)
Figure 41. Americas Humira Sales Market Share byType (2020-2025)
Figure 42. Americas Humira Sales Market Share by Application (2020-2025)
Figure 43. United States Humira Revenue Growth 2020-2025 ($ millions)
Figure 44. Canada Humira Revenue Growth 2020-2025 ($ millions)
Figure 45. Mexico Humira Revenue Growth 2020-2025 ($ millions)
Figure 46. Brazil Humira Revenue Growth 2020-2025 ($ millions)
Figure 47. APAC Humira Sales Market Share by Region in 2025
Figure 48. APAC Humira Revenue Market Share by Region (2020-2025)
Figure 49. APAC Humira Sales Market Share byType (2020-2025)
Figure 50. APAC Humira Sales Market Share by Application (2020-2025)
Figure 51. China Humira Revenue Growth 2020-2025 ($ millions)
Figure 52. Japan Humira Revenue Growth 2020-2025 ($ millions)
Figure 53. South Korea Humira Revenue Growth 2020-2025 ($ millions)
Figure 54. Southeast Asia Humira Revenue Growth 2020-2025 ($ millions)
Figure 55. India Humira Revenue Growth 2020-2025 ($ millions)
Figure 56. Australia Humira Revenue Growth 2020-2025 ($ millions)
Figure 57. ChinaTaiwan Humira Revenue Growth 2020-2025 ($ millions)
Figure 58. Europe Humira Sales Market Share by Country in 2025
Figure 59. Europe Humira Revenue Market Share by Country (2020-2025)
Figure 60. Europe Humira Sales Market Share byType (2020-2025)
Figure 61. Europe Humira Sales Market Share by Application (2020-2025)
Figure 62. Germany Humira Revenue Growth 2020-2025 ($ millions)
Figure 63.France Humira Revenue Growth 2020-2025 ($ millions)
Figure 64. UK Humira Revenue Growth 2020-2025 ($ millions)
Figure 65. Italy Humira Revenue Growth 2020-2025 ($ millions)
Figure 66. Russia Humira Revenue Growth 2020-2025 ($ millions)
Figure 67. Middle East & Africa Humira Sales Market Share by Country (2020-2025)
Figure 68. Middle East & Africa Humira Sales Market Share byType (2020-2025)
Figure 69. Middle East & Africa Humira Sales Market Share by Application (2020-2025)
Figure 70. Egypt Humira Revenue Growth 2020-2025 ($ millions)
Figure 71. South Africa Humira Revenue Growth 2020-2025 ($ millions)
Figure 72. Israel Humira Revenue Growth 2020-2025 ($ millions)
Figure 73.Turkey Humira Revenue Growth 2020-2025 ($ millions)
Figure 74. GCC Countries Humira Revenue Growth 2020-2025 ($ millions)
Figure 75. Manufacturing Cost Structure Analysis of Humira in 2025
Figure 76. Manufacturing Process Analysis of Humira
Figure 77. Industry Chain Structure of Humira
Figure 78. Channels of Distribution
Figure 79. Global Humira Sales MarketForecast by Region (2026-2031)
Figure 80. Global Humira Revenue Market ShareForecast by Region (2026-2031)
Figure 81. Global Humira Sales Market ShareForecast byType (2026-2031)
Figure 82. Global Humira Revenue Market ShareForecast byType (2026-2031)
Figure 83. Global Humira Sales Market ShareForecast by Application (2026-2031)
Figure 84. Global Humira Revenue Market ShareForecast by Application (2026-2031)
